Mechanical Thrombectomy Devices Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3362
Mechanical Thrombectomy Devices Market size is expected to grow significantly from 2019 to 2025.
Increasing prevalence of heart ailments such as myocardial infarction, blockage of veins and arteries due to accumulation of thrombus in various parts of bodies will propel the business growth. Changing lifestyle, lack of exercise and consumption of junk food lead to an increase in prevalence of cardiovascular diseases. According to CDC, every year 790,000 Americans suffer from myocardial infarction. Mechanical thrombectomy enables elimination of maximum thrombus burden that prevents risk of embolism. As a result, for treating chronic cardiovascular conditions demand for mechanical thrombectomy devices will increase that will positively impact industry growth during the forecast years.
Rising preference towards minimally invasive mechanical thrombectomy procedures will augment demand for mechanical thrombectomy devices. Patients are preferring minimally invasive mechanical thrombectomy procedures due to benefits such as less pain, effective treatment and quick patient recovery for treating cardiac diseases. Recently developed thrombectomy devices enable doctors to provide efficient and less invasive treatment. For instance, in 2018, Stryker developed thrombectomy device, that treats occlusions in arterial distal branches more securely. Aforementioned factors will create high demand in elderly population base for mechanical thrombectomy devices that will result in lucrative business growth. However, high cost of mechanical thrombectomy devices will hamper the industry growth to some extent.
Rheolytic thrombectomy segment is estimated to witness robust growth in analysis timeline. Rheolytic thrombectomy effectively targets extraction of thrombus from peripheral and vasculature. It creates saline jets into catheter wherein, it travels backward from tip at high speed. It minimizes complications involved in surgical procedures. As rheolytic thrombectomy is prominently effective in extracting non-organized thrombus, its demand is expected to exceed in the coming years.
Neurology segment is anticipated to show lucrative growth in near future owing to increasing prevalence of brain disorders. Rising prevalence of ischemic strokes caused due to clots in brain will create ample demand for mechanical thrombectomy devices. Ischemic stroke is caused due to large vessel occlusions that causes blockage in brain arteries. Technologically advanced thrombectomy devices are used in clot-disrupting, unclogging thrombus in cerebral vessels that are of size 2-5 mm. As a result, efficient treatment offered by these devices will foster the segment growth.
Ambulatory surgical centers is anticipated to witness significant growth in near future. ASCs offers minimally invasive surgical procedures that results in quick recovery time, less pain and efficient treatment results. As a result, patients are preferring treatment in ASCs. Moreover, prevalence of cardiovascular diseases is high in geriatric population. As a result, geriatric population facing affordability issues prefer ASCs for treatment that should stimulate the segmental growth.
North America mechanical thrombectomy devices market is projected to witness substantial growth in analysis time frame. Demographic trends such as rising geriatric population increasing prevalence of cardiac diseases will increase the demand for mechanical thrombectomy devices. Moreover, positive regulatory scenario for thrombectomy devices in North America will trigger the industry growth.
Some of the key players operating in mechanical thrombectomy devices are Argon Medical Devices Inc, Boston Scientific Corporation, BTG Vascular, Codman Neuro (Johnson & Johnson), Control Medical Technology, Euphrates Vascular, Inari Medical, Medtronic, NexGen Medical Systems, Inc., Penumbra, Inc. (Neuro), Stryker, Teleflex and Walk Vascular, LLC. For instance, in February 2018, Stryker developed Trevo Retriever that became first only device used for treatment up to 24 hours. The device complies with AHA/ASA guidelines. Thus, introduction of new products will render company with competitive advantage.
Mechanical Thrombectomy Devices Market By Type, 2014-2025 (USD Million)
- Aspiration Thrombectomy
- Rheolytic Thrombectomy
- Fragmentation Thrombectomy
- Ultrasound-assisted thrombolysis
Mechanical Thrombectomy Devices Market By Application, 2014-2025 (USD Million)
- Peripheral vascular
Mechanical Thrombectomy Devices Market By End-user, 2014-2025 (USD Million)
- Ambulatory Surgical Centers
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Argon Medical Devices, Inc.
- Boston Scientific Corporation
- BTG Vascular
- Codman Neuro (Johnson & Johnson)
- Control Medical Technology
- Euphrates Vascular
- Inari Medical
- NexGen Medical Systems, Inc.
- Penumbra, Inc. (Neuro)
- Walk Vascular, LLC
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability